Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
amyloidosis/palavik
Link salvestatakse lõikelauale
Leht 1 alates 17 tulemused
Evaluation of pentraxin3 as a Marker for Ventilator Associated Pneumonia
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Ventilator associated pneumonia (VAP) is a type of hospital-acquired pneumonia that occurs more than 48h after endotracheal intubation. This can be further classified into early onset (within the first 96 hours of mechanical ventilation (MV) and late onset (more than 96 hours after the initiation of
Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Erysipelas-like erythema (ELE) is the pathognomonic cutaneous manifestation of familial Mediterranean fever (FMF). It typically presents with painful, well-demarcated, and unilateral erythema overlying the ankle, and resolves spontaneously within 24 to 72 hours. Its incidence varies from 1% to 48%
Tocilizumab for the Treatment of Familial Mediterranean Fever
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FMF is a rare disease, which permanently affects daily life of the patients with severe pain and the risk of developing a life threatening amyloidosis. Today there are only very limited treatment options and an ongoing highly unmet medical need for improved treatment strategies. This study will be
Recurrent AA Amyloidosis After Renal Transplantation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
AA amyloidosis is a rare but serious complication of several chronic inflammatory diseases including recurrent hereditary periodic fever syndromes. Although end-stage renal disease related to AA amyloidosis is well characterized, there is limited data concerning patient and graft outcomes after
The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Study design This study was conducted by members of the FMF Arthritis Vasculitis and Orphan disease Research in Pediatric Rheumatology (FAVOR, www.favor.org.tr) at 10 centers in Turkey. This is a multicentric randomized controlled, noninferiority trial of two parallel groups being followed up in
Controlled Ceasing of Colchicine Therapy in Familial Mediterranean Fever (FMF) Patients With Single MEFV (Mediterranean Fever) Gene Mutation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The diagnosis of FMF is mainly clinical and genetic tests are only used to confirm the diagnosis . Even though the disease is autosomal recessive, not all FMF patients have two recognizable MEFV mutations. The phenotype of FMF patients varies according to the genotype, as shown by a number of
Association Between Basal Proteinuria Levels and Pregnancy Outcomes in Familial Mediterranean Fever
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Familial Mediterranean fever (FMF) is also known recurrent polyserositis the most common hereditary recurrent febrile disorder. It is characterized by paroxysmal episodes of the high fever and signs of serositis-peritonitis, pleuritis, synovitis. Between these attacks, patients are usually
Kineret (Anakinra), in Adult Patients With Colchicine-Resistant Familial Mediterranean Fever
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Progression of Renal Amyloidosis of FMF and Relation to Serum SAA Level
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FMF is an inherited inflammatory disorder typically presented in most causes as recurrent episodes of fever and serositis. Phenotype II, another kind of this disorder, has atypical courses, when the inflammation proceeds without any clinical sign.
Each FMF attack is accompanied by sharp elevation of
Pharmacokinetics Study of Colchicine in Familial Mediterranean Fever (FMF) Patients
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
FMF patients who have not been taking colchicine (colchicine-naïve patients) will be enrolled into a 1 week dose-titration period (Days -7 to -1). Beginning on Day -7, a pre-dose blood sample will be collected from the colchicine-naïve patient population for determination of pharmacodynamic markers.
Schnitzler Syndrome: Clinical Study, Physiopathological and Search for Genetic Factors
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Pravastatin and Ventilatory Associated Pneumonia
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
INTRODUCTION
The pneumonia in the intensive care unit (I.C.U.) constitutes the most frequent infection and is most often associated with the application of the mechanical ventilation. VAP (Ventilator - Associated Pneumonia) is defined as the nosocomial pneumonia in a patient on mechanical
Trial of Two Stem Cell Doses To Reduce Transplant Induced Symptom Burden
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Stem cells are found in the bone marrow and bloodstream, and they rebuild blood, bone marrow, and the immune system. This study uses autologous stem cells, which are stem cells collected from your own blood. Melphalan is designed to damage the DNA (the genetic material) of cells, which may cause
Rilonacept for Treatment of Familial Mediterranean Fever (FMF)
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Familial Mediterranean fever (FMF) is an autosomal recessive autoinflammatory genetic disorder resulting in recurrent attacks of fever, serositis, arthritis and rash. Late complications of untreated FMF include the development of renal amyloidosis. FMF is a rare orphan disease in the United States.
Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic Inflammation
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Population:Morbidly obese non-smoking patients of the Department of Gastroenterology, candidates for possible bariatric treatment Criteria for inclusion: Males and females, 18- 65 years old, body mass index/BMI > 40 kg/m2 (or > 35 kg/m2 with comorbidities), non-hospitalized and receiving general
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
